Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
31/03/2023 16:14
March 31 (Reuters) - PURE BIOLOGICS SA PUR1.WA :
* FY 2022 NET LOSS OF 25.6 MILLION ZLOTYS VERSUS LOSS OF
11.8
MILLION ZLOTYS YEAR AGO
* FY 2022 OPERATING REVENUE AT 13.5 MILLION ZLOTYS VERSUS
18.0
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM3RF8Zka
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects